Laura Quevedo

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Ester Molina, Lucía García-Gutiérrez, Vanessa Junco, Mercedes Perez-Olivares, Virginia G de Yébenes, Rosa Blanco, Laura Quevedo, Juan Carlos Acosta, Ana V Marín, Daniela Ulgiati, Ramon Merino, M Dolores Delgado, Ignacio Varela, José R Regueiro, Ignacio Moreno de Alborán, Almudena R Ramiro, Javier León
MYC directly transactivates CR2/CD21, the receptor of the Epstein-Barr virus, enhancing the viral infection of Burkitt lymphoma cells. Oncogene (2023)
Olga Boix, Marion Martinez, Santiago Vidal, Marta Giménez-Alejandre, Lluís Palenzuela, Laura Lorenzo-Sanz, Laura Quevedo, Olivier Moscoso, Jorge Ruiz-Orera, Pilar Ximénez-Embún, Nikaoly Ciriaco, Paolo G Nuciforo, Camille Stephan-Otto Attolini, M Mar Albà, Javier Munoz, Tian V Tian, Ignacio Varela, Ana Vivancos, Santiago Ramón Y Cajal, Purificación Muñoz, Carmen Rivas, María Abad
pTINCR microprotein promotes epithelial differentiation and suppresses tumor growth through CDC42 SUMOylation and activation. Nature communications 13 (1) (2022)
Thaidy Moreno, Beatriz Monterde, Laura González-Silva, Isabel Betancor-Fernández, Carlos Revilla, Antonio Agraz-Doblas, Javier Freire, Pablo Isidro, Laura Quevedo, Rosa Blanco, Santiago Montes-Moreno, Laura Cereceda, María Aurora Astudillo, Berta Casar, Piero Crespo, Cristina Morales Torres, Paola Scaffidi, Javier Gómez-Román, Eduardo Salido, Ignacio Varela
ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancer. Oncogene 40 (16) (2021)